110 related articles for article (PubMed ID: 8177907)
21. Lifetime overproduction of circulating Angiotensin-(1-7) attenuates deoxycorticosterone acetate-salt hypertension-induced cardiac dysfunction and remodeling.
Santiago NM; Guimarães PS; Sirvente RA; Oliveira LA; Irigoyen MC; Santos RA; Campagnole-Santos MJ
Hypertension; 2010 Apr; 55(4):889-96. PubMed ID: 20212262
[TBL] [Abstract][Full Text] [Related]
22. Myocardial performance in conscious streptozotocin diabetic rats.
Borges GR; de Oliveira M; Salgado HC; Fazan R
Cardiovasc Diabetol; 2006 Dec; 5():26. PubMed ID: 17144912
[TBL] [Abstract][Full Text] [Related]
23. Fructose loading induces cardiovascular and metabolic changes in nondiabetic and diabetic rats.
Dai S; Todd ME; Lee S; McNeill JH
Can J Physiol Pharmacol; 1994 Jul; 72(7):771-81. PubMed ID: 7828085
[TBL] [Abstract][Full Text] [Related]
24. Interactions between hypertension and diabetes on vascular function and structure in rats.
Tilton RG; Pugliese G; Faller AM; LaRose LS; Province MA; Williamson JR
J Diabetes Complications; 1992; 6(3):187-96. PubMed ID: 1472745
[TBL] [Abstract][Full Text] [Related]
25. Effects of chronic treatment with amlodipine in streptozotocin-diabetic and spontaneously hypertensive rats.
Srinivasan PS; Hakim ZS; Santani DD; Goyal RK
Pharmacol Res; 1997 May; 35(5):423-8. PubMed ID: 9299205
[TBL] [Abstract][Full Text] [Related]
26. Effect of a methionine-supplemented diet on the blood pressure of Sprague-Dawley and deoxycorticosterone acetate-salt hypertensive rats.
Robin S; Maupoil V; Laurant P; Jacqueson A; Berthelot A
Br J Nutr; 2004 Jun; 91(6):857-65. PubMed ID: 15182389
[TBL] [Abstract][Full Text] [Related]
27. Digoxin amplifies the effects of deoxycorticosterone acetate (DOCA) in intact water-drinking rats: implications for the mechanism of DOCA hypertension?
Li M; Martin A; Liu DT; Whitworth JA
J Hypertens; 1994 May; 12(5):569-76. PubMed ID: 7930557
[TBL] [Abstract][Full Text] [Related]
28. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats.
Diaz J; Ni W; Thompson J; King A; Fink GD; Watts SW
J Pharmacol Exp Ther; 2008 Jun; 325(3):1031-8. PubMed ID: 18305011
[TBL] [Abstract][Full Text] [Related]
29. Effect of hypertension on the development of diabetic cardiomyopathy.
Mathis DR; Liu SS; Rodrigues BB; McNeill JH
Can J Physiol Pharmacol; 2000 Oct; 78(10):791-8. PubMed ID: 11077979
[TBL] [Abstract][Full Text] [Related]
30. Role of fibrillin-1 in hypertensive and diabetic glomerular disease.
Hartner A; Schaefer L; Porst M; Cordasic N; Gabriel A; Klanke B; Reinhardt DP; Hilgers KF
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1329-36. PubMed ID: 16380460
[TBL] [Abstract][Full Text] [Related]
31. L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats.
O'Brien D; Chunduri P; Iyer A; Brown L
Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):296-301. PubMed ID: 20041879
[TBL] [Abstract][Full Text] [Related]
32. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
[TBL] [Abstract][Full Text] [Related]
33. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation.
Prahalathan P; Kumar S; Raja B
Metabolism; 2012 Aug; 61(8):1087-99. PubMed ID: 22386933
[TBL] [Abstract][Full Text] [Related]
34. Coexistence of diabetes and hypertension results in unique structural alterations in the renal artery in rats beyond that found with diabetes alone.
Todd ME; Song MY; McNeill JH
Diabetes Res Clin Pract; 1993 Feb; 19(2):115-26. PubMed ID: 8472626
[TBL] [Abstract][Full Text] [Related]
35. Estrogen metabolite 2-methoxyestradiol prevents hypertension in deoxycorticosterone acetate-salt rats.
Yuan W; Yu Y; Li J; Singh P; Li D; Gui Y; Zheng XL
Cardiovasc Drugs Ther; 2013 Feb; 27(1):17-22. PubMed ID: 23229845
[TBL] [Abstract][Full Text] [Related]
36. Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats.
Wang DS; Xie HH; Shen FM; Cai GJ; Su DF
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):545-52. PubMed ID: 16026514
[TBL] [Abstract][Full Text] [Related]
37. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chen CC; Chang NC
Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
[TBL] [Abstract][Full Text] [Related]
38. Cardiac function of the diabetic renovascular hypertensive rat: effects of insulin and thyroid hormone treatment.
Rodgers RL; Davidoff AJ; Mariani MJ
Can J Physiol Pharmacol; 1991 Mar; 69(3):346-54. PubMed ID: 2059900
[TBL] [Abstract][Full Text] [Related]
39. Role of AT1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats.
Awad AS
Vascul Pharmacol; 2006 Sep; 45(3):141-7. PubMed ID: 16959546
[TBL] [Abstract][Full Text] [Related]
40. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
